Neurosense Therapeutics Ltd (NRSNW) SEC News Sept. 04, 2025, 13:02 UTC New Form 6-K - NeuroSense Therapeutics Ltd. Filed: 2025-09-04 AccNo: 0001213900-25-084296 Size: 14 KB Full text
There are no comments here yet...